WHO ICTRP trial
Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and…
PER-053-08 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-053-08 |
|---|---|
| Public title | Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes |
| Scientific title | Randomized, Multinational, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20 mg OD for Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients With Clustering Risk Factors |
| Primary sponsor | sanofi-aventis Recherche & Development, |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | III |
| Countries | Germany;Belgium;Denmark;Spain;Finland;Greece;Hungary;Ireland;Italy;Portugal;United Kindgdom;Sweden;Czech Republic;Peru |
| Conditions | -E669 Obesity, unspecified Obesity, unspecified;E669;Obesity, unspecified |
| Interventions | Group name:Group 1 Type of group;1 N° of participants:8500 Intervention(s) description:(rimonabant 20 mg): administration once a day in the morning of a tablet containing 20 mg of active rimonabant Group name:Group 2 Type of group;2 N° of… |
| Registration date | Oct 7, 2008 |
| Target size | 100 |
| Secondary IDs | NCT00263042;EUCTR2005-002942-20-SE |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: